Characteristics Patients with Borderline Ovarian Tumor at Sanglah General Hospital: From Pre- to Post-operative Approach

Nyoman Gede Budiana; Polo Ishak Kurniawan

doi:10.3889/oamjms.2022.8498

Authors

Nyoman Gede Budiana Department of Obstetrics and Gynecology, School of Medicine, Udayana University, Sanglah Hospital, Kuta Selatan, Indonesia
Polo Ishak Kurniawan Department of Obstetrics and Gynecology, School of Medicine, Udayana University, Sanglah Hospital, Kuta Selatan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.8498

Keywords:

Borderline ovarian tumor, Patient characteristics, Sociodemographic factors, Hormonal factors, Clinical factors, Outcome factors

Abstract

BACKGROUND: Specific epidemiology data of borderline ovarian tumor (BOT) might be beneficial for the early diagnosis of BOT. The scarcity of BOT epidemiological data in Indonesia urged the writer to study further.

AIM: The objectives of the study were to obtain the characteristics of BOT patients in Sanglah General Hospital between 2018 and 2019 according to sociodemographic, hormonal, clinical, and patient outcome factors.

METHODOLOGY: This is a descriptive retrospective study. Data were obtained from patient’s medical records at medical records installation Sanglah General Hospital between March 2020 and July 2020. Descriptive data collected from medical records were analyzed using Microsoft Excel 2010 and presented in tables and narrative form.

RESULTS: From sociodemographic factors, we found that majority of BOT patients were >40 years old, multiparous women, married, low educated, housewives, and had normal BMI. From hormonal factors, we found that experienced menarche between 11 and 15 years old, most of the patients were already menopause, did not use any contraception. From clinical factors, we found that many were referral cases, with abdominal pain as the main complaint, varied CA 125 and risk of malignancy index levels, unilateral mass, suspected with malignant ovarian cyst when being diagnosed earlier. From patient outcome factors, we found that the majority underwent definitive surgery with no post-operative CA 125 level, no malignant cells on cytology examination, borderline mucinous type in both frozen section and paraffin block examination, and followed up after surgery.

CONCLUSIONS: Clinicians could use these characteristics as a reference in diagnosing a patient who fits the profile.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Skírnisdóttir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: Trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 2008;123(8):1897-901. https://doi.org/10.1002/ijc.23724 PMid:18661518 DOI: https://doi.org/10.1002/ijc.23724

Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: A population among analysis. Cancer. 2004;100(5):1045-52. https://doi.org/10.1002/cncr.20080 PMid:14983501 DOI: https://doi.org/10.1002/cncr.20080

Benedet JL, Pecorelli S, Ngan HY, Hacker NF, Denny L, Jones HW, et al. Staging classifications and clinical practice guidelines for gynecological cancers. Int J Gynecol Obstet. 2000;70(2):207-312. PMid:11041682

Fruscella E, Testa AC, Ferrandina G, De Smet F, Van Holsbeke C, Scambia G, et al. Ultrasound features of different histopathological subtypes of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005;26(6):644-50. https://doi.org/10.1002/uog.2607 PMid:16254875 DOI: https://doi.org/10.1002/uog.2607

Bent CL, Sahdev A, Rockall AG, Singh N, Sohaib SA, Reznek RH. MRI appearances of borderline ovarian tumors. Clin Radiol. 2009;64(4):430-8. https://doi.org/10.1002/uog.2607 PMid:19264189 DOI: https://doi.org/10.1016/j.crad.2008.09.011

Ju W, Kim SC. The discrepancy between magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography imaging in a case of borderline ovarian tumor. Int J Gynecol Cancer. 2007;17(5):1031-3. https://doi.org/10.1111/j.1525-1438.2007.00923.x PMid:17386039 DOI: https://doi.org/10.1111/j.1525-1438.2007.00923.x

Yamamoto Y, Oguri H, Yamada R, Maeda N, Kohsaki S, Fukaya T. Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography. Int J Gynecol Obstet. 2008;102(2):124-7. https://doi.org/10.1016/j.ijgo.2008.02.019 PMid:18423470 DOI: https://doi.org/10.1016/j.ijgo.2008.02.019

Link CJ, Reed E, Sarosy G, Kohn EC. Borderline ovarian tumors. Am J Med. 1996;101(2):217-25. https://doi.org/10.1016/s0002-9343(96)80079-9 PMid:8757363 DOI: https://doi.org/10.1016/S0002-9343(96)80079-9

Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75(1):92-6. https://doi.org/10.1016/s0015-0282(00)01633-2 PMid:11163822 DOI: https://doi.org/10.1016/S0015-0282(00)01633-2

Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early-stage invasive ovarian cancer. Gynecol Oncol. 2005;97(3):780-3. https://doi.org/10.1016/j.ygyno.2005.02.022 PMid:15893369 DOI: https://doi.org/10.1016/j.ygyno.2005.02.022

Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM, et al. Williams Gynecology. 4th ed. New York: McGraw Hill Professional; 2020. p. 1328.

Ayhan A, Guven ES, Guven S, Kucukali T. Recurrence and prognostic factors in borderline ovarian tumors. Gynecol Oncol. 2005;98(3):439-45 https://doi.org/10.1016/j.ygyno.2005.05.033 PMid:16009407 DOI: https://doi.org/10.1016/j.ygyno.2005.05.033

Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104(2):228-32. https://doi.org/10.1002/ijc.10927 PMid:1256957 DOI: https://doi.org/10.1002/ijc.10927

Gracella GM. Ovarian Tumor Prevalence and Description at Dr. M. Salamun Bandung January 2014-December 2016. (Undergraduate Thesis), Bandung: Universitas Kristen Maranatha; 2017. https://doi.org/10.21776/ ub.mps.2021.007.01.3

Yoshida A, Tavares BV, Sarian LO, Andrade LA, Derchain SF. Clinical features and management of women with borderline ovarian tumors in a single center in Brazil. Rev Bras Ginecol Obstet. 2019;41(3):176-82. https://doi.org/10.1055/s-0039-1683415 PMid:30991432 DOI: https://doi.org/10.1055/s-0039-1683415

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, et al. Risk factors for epithelial borderline ovarian tumors: Results of a Swedish case-control study. Gynecol Oncol. 2001;83(3):575-85. https://doi.org/10.1006/gyno.2001.6451 PMid:11733975 DOI: https://doi.org/10.1006/gyno.2001.6451

Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies: III. Epithelial tumors of low malignant potential in white women. Collaborative ovarian cancer group. Am J Epidemiol. 1992;136(10):1204-11. https://doi.org/10.1093/oxfordjournals.aje.a116428 PMid:1476142 DOI: https://doi.org/10.1093/oxfordjournals.aje.a116428

Kolwijck E, Thomas CM, Bulten J, Massuger LF. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: A retrospective analysis and review of the literature. Int J Gynecol Cancer. 2009;19(8):1335-8. https://doi.org/10.1111/igc.0b013e3181a83e04 PMid:20009886 DOI: https://doi.org/10.1111/IGC.0b013e3181a83e04

Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol. 2007;25(20):2928-37. https://doi.org/10.1200/jco.2007.10.8076 PMid:17617524 DOI: https://doi.org/10.1200/JCO.2007.10.8076

Sneige N, Thomison JB, Malpica A, Gong Y, Ensor J, Silva EG. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Cancer Cytopathol. 2012;120(4):238-44. https://doi.org/10.1002/cncy.21219 PMid:22826172 DOI: https://doi.org/10.1002/cncy.21219

Hannibal CG, Huusom LD, Kjaerbye‐Thygesen AN, Tabor A, Kjaer SK. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006. Acta Obstet Gynecol Scand. 2011;90(4):305-12. https://doi.org/10.1111/j.1600-0412.2010.01060.x PMid:21306323 DOI: https://doi.org/10.1111/j.1600-0412.2010.01060.x

Arshad NZ, Ng BK, Paiman NA, Mahdy ZA, Noor RM. Intra-operative frozen sections for ovarian tumors a tertiary center experience. Asian Pacific J Cancer Prev. 2018;19(1):213. https://doi.org/10.22034/APJCP.2018.19.1.213 PMid:29373916

Huang Z, Li L, Li C, Ngaujah S, Yao S, Chu R, et al. Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: A meta-analysis with emphasis on misdiagnosis factors. J Cancer. 2018;9(16):2817. https://doi.org/10.7150/jca.25883 PMid:30123350 DOI: https://doi.org/10.7150/jca.25883